Abstract
In this chapter the biochemical diagnosis of OXPHOS disorders is presented. The laboratory investigations in suspected patients are started with the examination of body fluids. The most important metabolite to be measured is lactate, that is frequendy found to be elevated in blood, urine and cerebrospinal fluid of patients with OXPHOS disorders. The next step in the diagnostic procedure consists of the examination of tissues. The biochemical diagnostic investigations are preferably performed in muscle tissue because in most patients the defect is expressed in muscle. Biopsy material is preferred above autopsy material. Biochemical examination of a fresh muscle sample is to be preferred because mitochondria are intact in fresh muscle thus allowing measurement of the overall oxidative capacity of the mitochondria. In a frozen muscle sample only enzyme activities of the OXPHOS complexes can be measured. In the latter case patients with a disturbance in the oxidative phosphorylation not localized in one of the OXPHOS complexes remain undiagnosed. Practical guidelines for the biochemical examinations of muscle are provided. In certain circumstances it is necessary to examine also fibroblasts. This is an absolute prerequisite in case prenatal diagnosis is requested. The interpre-tation of the biochemical investigations is discussed with special emphasis on the observed residual enzyme activities.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Smeitink J, van den Heuvel L. Human mitochondrial complex I in health and disease. Am J Hum Genet 1999; 64:1505–1510.
Willems JL, Monnens LAH, Trijbels JMF et al. Leigh’s encephalomyopathy in a patient with cytochrome c oxidase deficiency in muscle tissue. Pediatrics 1977; 60:850–857.
Bookelman H, Trijbels JMF, Sengers RCA et al. Pyruvate oxidation in rat and human skeletal muscle mitochondria. Biochem Med 1978; 20:395–403.
Fischer JC, Ruitenbeek W, Trijbels JMF et al. Estimation of NADH oxidation in human skeletal muscle mitochondria. Clin Chim Acta 1986; 155:263–274.
Fischer JC, Ruitenbeek W, Berden JA et al. Differential investigation of the capacity of succinate oxidation in human skeletal muscle. Clin Chim Acta 1985; 153:23–36.
Cooperstein SJ, Lazarow A. A microspectrophotometric method for the determination of cytochrome oxidase. J Biol Chem 1951; 189:665–670.
Ruitenbeek W, Trijbels JMF, Fischer JC et al. Mitochondrial myopathies: multiple enzyme defects in the respiratory chain. J Inher Metab Dis 1989; 12(suppl. 2):352–354.
Sperl W, Ruitenbeek W, Sengers RCA et al. Combined deficiencies of the pyruvate dehydrogenase complex and enzymes of the respiratory chain in mitochondrial myopathies. Eur J Pediatr 1992; 151:192–195.
Janssen AJM, Smeitink J, van den Heuvel LP. Some practical aspects of providing a diagnostic service for respiratory chain defects. Ann Clin Biochem 2003; 40:3–8.
Sperl W, Sengers RCA, Trijbels JMF et al. Enzyme activities of the mitochondrial energy generating system in skeletal muscle tissue of preterm and fullterm neonates. Ann Clin Biochem 1992; 29:638–646.
Chretien D, Gallego J, Barrientos A et al. Biochemical parameters for the diagnosis of mitochondrial respiratory chain deficiency in humans, and their lack of age-related changes. Biochem J 1998; 329:249–254.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2004 Eurekah.com and Kluwer Academic / Plenum Publishers
About this chapter
Cite this chapter
Trijbels, J.M.F., Janssen, A.J.M., van den Heuvel, L.P., Sengers, R.C.A., Smeitink, J.A.M. (2004). Biochemical Diagnosis of OXPHOS Disorders. In: Oxidative Phosphorylation in Health and Disease. Medical Intelligence Unit. Springer, Boston, MA. https://doi.org/10.1007/0-387-26992-4_5
Download citation
DOI: https://doi.org/10.1007/0-387-26992-4_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-48232-8
Online ISBN: 978-0-387-26992-4
eBook Packages: MedicineMedicine (R0)